Scientists have discovered two useful new enzymes which may help them create medicines for cancer and other conditions. The enzymes were found in the Natural Products Discovery Center collection.
Nancy G. Brinker Founder of Susan G. Komen and the Promise Fund of Florida, Recipient of the Presidential Medal of Freedom, U.S. Ambassador and Lifetime Member of the Council on Foreign Relations Nancy G. Brinker Nancy G. Brinker has been described as the leader of the global breast cancer movement.
Chemistry Professor Thomas Kodadek, Ph.D., has won a third Transformative Research Award from the National Institutes of Health for his plan to capitalize on cells' protein recycling machinery as a way to fight cancer.
The scientists’ approach directs cells’ recycling enzymes to cancer genes’ RNA and cuts up key segments to prevent them from doing harm. The tactic worked against the MYC cancer gene, and also two other challenging cancer genes.
Inside cells, protein factories called ribosomes have a unique way of patching oxidative stress damage, according to a new discovery from the Karbstein lab.
A bioresponsive sensor from Carroll lab activates antioxidants only when needed and provides a tool for studying free radicals' role in disease.
Glioblastoma is fast-moving, and the most common type of brain cancer. Two specific cancer cell mutations may work together to help hide these tumors from the immune system, a study from Janiszewska finds.
A team led by chemistry professor Ben Shen, Ph.D., discovered a potent anti-cancer compound within the institute's natural products collection. It has been connected to a precise cancer-seeking antibody with an innovative linker molecule.
Florida’s statewide biotechnology industry organization, BioFlorida, awarded its 2022 Weaver H. Gaines Entrepreneur of the Year award to Courtney Miller, Ph.D.
Enediynes can bind and break DNA, leading to cell death. As a result, they have enormous potential as antibiotics and cancer drugs. A new study reveals how nature assembles them.
